Genpharmasec Limited, established in 1992, is primarily engaged in pharmaceutical activities and trading in equity shares, initially focusing on chemicals and pigments manufacturing.

The company pivoted in 2018 towards pharmaceuticals and ventured into securities trading, marking a strategic shift in operations.

In 2019, Genpharmasec entered the medical device segment, securing distribution rights for Abbott's diagnostic equipment, a move aimed at diversification.

Recently, the company enhanced profitability by importing Abbott cartridges directly, cementing its position in the diagnostic equipment distribution sector.

With consistent efforts to expand beyond single partnerships, Genpharmasec is actively seeking growth opportunities to avoid sales stagnation.